Position in DNLI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$832,550
+$574,603 QoQ
Shares Held
43,362
+135.2% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,861,226 across 147 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
29,790 | $3,954,026 | |
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in DNLI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $832,550 | 43,362 | Shares | Defined | 2026-05-14 | |
| 2025-06-30 | $257,947 | 18,438 | Shares | Defined | 2025-08-12 | |
| 2023-12-31 | $334,260 | 15,576 | Shares | Defined | 2024-02-26 | |
| 2020-12-31 | $282,522 | 3,373 | Shares | Defined | 2021-02-24 | |
| 2020-09-30 | $279,509 | 7,801 | Shares | Defined | 2020-12-11 | |
| No filing history on record for this holder in this stock. | ||||||